The Global Partnership for Zero Leprosy (GPZL) is a coalition committed to ending leprosy, also known as Hansen’s disease. Our members include individuals and organizations who share our triple-zero vision of no disease, no disability, and no discrimination or stigma.
Our Impact
- organizational members
- individual members
- country partnerships
- best practices
The Challenge
200,000 people
diagnosed each year5 million people
living with leprosy-related disability and stigma150 countries
with active transmission130 laws
discriminate against people who have experienced leprosy
Our Strategy
Country Partnership
We work with country governments and convene international and in-country stakeholders to map leprosy and scale up deployment of zero transmission tools.
Research Acceleration
We build consensus on critical research to interrupt transmission and steer researchers, investors and developers on the path towards zero transmission research priorities.
Prioritizing People
We promote a person-centred approach to leprosy services and set global standards for the prioritization of people and their rights in the journey towards zero leprosy.
Zero Leprosy Toolkit
The Zero Leprosy Toolkit is a free set of field-tested best practices designed to support countries in their work toward ending leprosy and its associated disabilities and stigma.
Subscribe to Newsletter
Receive monthly updates on our progress toward zero leprosy and opportunities to get involved.
Recent News
10 March 2025
Call for Nominations – Representatives National Leprosy Programs for GPZL Members’ Assembly
The Global Partnership for Zero Leprosy (GPZL) is seeking nominations for Representatives of National Leprosy Programs to serve on its Members’ Assembly for a two-year term, renewable once. The term will begin on 1 April 2025.
Read more >10 March 2025
GPZL Seeks Supply Chain Consultant
With the support of GPZL partner organizations, the consultant will conduct a comprehensive assessment of MDT, Clofazimine, Prednisolone, and Rifampicin supply chain challenges in the selected countries, identifying inefficiencies, key barriers, and opportunities for improvement.
Read more >